OptimizeRx Corporation - Common Stock (NQ:OPRX)

8.290 -0.130 (-1.54%)

Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

August 07, 2025

From OptimizeRx Corporation

Via GlobeNewswire

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

July 17, 2025

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

June 24, 2025

From OptimizeRx Corporation

Via GlobeNewswire

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Where OptimizeRx Stands With Analysts ↗

February 06, 2025

Via Benzinga

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

June 20, 2025

From Simulmedia

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 20, 2025

Via Benzinga

OptimizeRx to Participate in Upcoming Investor Conferences

May 16, 2025

From OptimizeRx Corporation

Via GlobeNewswire

There are notable gap-ups and gap-downs in today's session. ↗

May 13, 2025

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Which stocks are moving before the opening bell on Tuesday? ↗

May 13, 2025

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert ↗

May 13, 2025

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 12, 2025

Via Benzinga

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

May 12, 2025

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

May 01, 2025

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

April 23, 2025

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

April 18, 2025

From OptimizeRx Corporation

Via GlobeNewswire

Unusual volume stocks in Thursday's session ↗

March 13, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

Top movers in Wednesday's session ↗

March 12, 2025

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are experiencing notable movement on Wednesday? ↗

March 12, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 12, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 12, 2025

In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million ↗

March 12, 2025

OptimizeRx reports sales of $32.32M in Q4, beating consensus, with adjusted EPS of $0.30. Full-year revenue increased 29% and EBITDA grew 53%.

Via Benzinga

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

March 12, 2025

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

March 11, 2025

No Stockholder Action Required at this Time

From OptimizeRx Corporation

Via GlobeNewswire

Earnings Scheduled For March 12, 2025 ↗

March 12, 2025

Via Benzinga

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

March 10, 2025

Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

February 27, 2025

From OptimizeRx Corporation

Via GlobeNewswire

CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 24, 2024

Via Benzinga

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

December 23, 2024

From OptimizeRx Corporation

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.